• 1
    Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464470.
  • 2
    Freeman RB. Around the world with MELD. Liver Transpl 2003; 9: 11181120.
  • 3
    Child CG II, Turcotte JG. Surgery and portal hypertension. In: ChildCGIII, ed. The liver and portal hypertension. Philadelphia. PA: Saunders, 1964; 5058.
  • 4
    Department of Health and Human Services “Final Rule'” 64 FR 56658, Oct. 20, 1999.
  • 5
    Freeman RB, Weisner RH, Harper A, McDairmid SV, Lake J, Edwards EB, et al. The New Liver Allocation System: moving towards evidence-based transplantation policy. Liver Transpl 2002; 8: 851858.
  • 6
    Stell DA, McAlistair VC, Thorburn D. A comparison of disease severity and survival rates after liver transplantation in the United Kingdom, Canada, and the United States. Liver Transpl 2004; 10: 898902.
  • 7
    Wiesner RH, Edwards EB, Freeman RB, Harper A, Kim R, Kamath P, et al. Model for end stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 9196.
  • 8
    Wiesner RH, McDairmid SV, Kamath PS, Edwards B, Malinchoc M, Kremers WK, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7: 567580.
  • 9
    Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 2936.
  • 10
    Neuberger J. Allocation of donor livers-Is MELD enough? Liver Transpl 2004; 10: 908910.
  • 11
    Heuman DM, Abou-assi SG, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004; 40: 802810.
  • 12
    Merion RM, Wolfe RA, Dystra DM, Leichtman AB, Gillespie B, Held PJ. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl 2003; 9: 1921.
  • 13
    Bambha K, Kim WR, Kremers WK, Therneau TM, Kamath PS, Wiesner R, et al. Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant 2004 (in press).
  • 14
    Kim RW. Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology 2004 (in press).
  • 15
    Ganes P, Fernandez-Esparrach G. Prognosis of cirrhosis with ascites. In: ArroyoV, RodesJ, eds. Ascites and Renal Dysfunction in Liver Cirrhosis. Pathogenisis, Diganosis and Treatment. Malden, MA, Blackwell Scientific; 1999: 431441.
  • 16
    Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology 1994; 20 (1 Pt 1): 119125.
  • 17
    Porcel A, Diaz F, Rendon P, Macias M, Martin-Herrera L. Giron-Gonzalez JA. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Int Med 2002; 162: 323328.
  • 18
    Arroyo V, Jimenez W. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol 2000; 32 (Suppl): 157170.
  • 19
    Llach J, Ginès P, Arroyo V, Rimola A, Titó L, Badalamenti S, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988; 94: 482487.
  • 20
    Ruf AE, Yantorno SE, Descalzi VI, Andriani OC, Podesta LG, Vilamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone-A single center experience. Am J Transplant 2004; 4 (Suppl 8): 438.
  • 21
    Freeman RB, Wiesner RH, Harper A, Edwards EB, Merion RB, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl 2004; 10: 715.
  • 22
    Olthoff KA, Brown RS, Delmonico FA, Freeman RB, Lucey M, McDiarmid SV, et al. Evolving concepts in liver allocation in the MELD/PELD Era. Am J Transplant 2004 (in press).